NDC 12527-8513-09: ciprofloxacin hydrochloride 500 mg Tablet, Film Coated, 83,486-count
This is a package of 83,486 tablets of ciprofloxacin hydrochloride 500 mg Tablet, Film Coated from Bayer AG, first listed with the FDA Aug 1997 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 12527-8513-9 alone.
- Record
- FDA NDC Directory package listing · Drug for further processing
- Code segments
- 12527 labeler · 8513 product · 9 package
- Package marketed since
- Jul 2, 2019
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 1252785139 4
- FDA record last changed
- Oct 15, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
- It treats bacterial infections such as urinary tract, respiratory, skin, bone and abdominal infections, depending on the form. Eye and ear versions treat eye and ear infections. It...
- Swallow them as prescribed, usually every 12 hours, and finish the full course unless your doctor says otherwise. Keep them 2 hours before or 6 hours after antacids, multivitamins,...
- How should I take my ciprofloxacin tablets?
- The most common ones are nausea, diarrhea, vomiting, rash and abnormal liver tests. Most are mild, but tell your doctor if they bother you.
Patient education
Drug interactions
Supplement & herbal interactions
Ciprofloxacin may be associated with lower levels of 11 nutrients — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 12527-8513-09 You're viewing this Main listing | 83486 TABLET, FILM COATED in 1 CONTAINER | — | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Ciprofloxacin 500 mg 61442-0223-01 | Carlsbad | 100 tablets | $0.123 | AB | Availability likely | — |
| Ciprofloxacin 500 mg 65862-0077-01 | Aurobindo | 100 tablets | $0.123 | AB | Availability likely | — |
| Ciprofloxacin 500 mg 60687-0947-01 | American | 1 tablet | $0.123 | AB | Availability likely | — |
| Ciprofloxacin 500 mg 60687-0860-01 | American | 1 tablet | $0.123 | AB | Availability likely | — |
| Ciprofloxacin Hydrochloride 500 mg 69367-0386-01 | Westminster | 100 tablets | $0.123 | AB | Availability likely | — |
| Ciprofloxacin 500 mg 62135-0309-01 | Chartwell | 100 tablets | $0.123 | AB | Availability likely | — |
| Ciprofloxacin 500 mg 59651-0867-01 | Aurobindo | 100 tablets | $0.123 | AB | Availability likely | — |
| Ciprofloxacin 500 mg 71205-0997-00 | Proficient | 100 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 71610-0109-30 | Aphena | 30 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 71610-0159-83 | Aphena | 3600 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 63629-1010-01 | Bryant | 100 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 70934-0965-06 | Denton | 6 tablets | — | AB | Discontinued | — |
| Ciprofloxacin 500 mg 72789-0065-20 | PD-Rx | 20 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 00615-8546-10 | NCS | 10 tablets | — | AB | Discontinued | — |
| Ciprofloxacin Hydrochloride 500 mg 83939-0002-01 | VERITYRX, | 1 tablet | — | AB | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 50090-7843-00 | A-S | 20 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 72162-1741-02 | Bryant | 14 tablets | — | AB | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 82804-0260-06 | Proficient | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 50090-3791-00 | A-S | 20 tablets | — | AB | Discontinued | — |
| Ciprofloxacin 500 mg 51407-0165-01 | Golden | 100 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 59651-0977-15 | Aurobindo | 1500 tablets | — | AB | FDA listed | — |
| Cipro 500 mg 50419-0754-01 | Bayer | 100 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 51655-0216-20 | Northwind | 20 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 72789-0511-10 | PD-Rx | 10 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 50090-3852-00 | A-S | 20 tablets | — | AB | Discontinued | — |
| Ciprofloxacin Hydrochloride 500 mg 67296-2208-01 | Redpharm | 10 tablets | — | AB | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 80425-0493-01 | Advanced | 20 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 82982-0050-14 | Pharmasource | 14 tablets | — | AB | Discontinued | — |
| Ciprofloxacin 500 mg 43063-0923-02 | PD-Rx | 2 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 50090-5373-00 | A-S | 20 tablets | — | AB | Discontinued | — |
| Ciprofloxacin 500 mg 71205-0649-06 | Proficient | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 76420-0045-06 | Asclemed | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 00615-8630-10 | NCS | 10 tablets | — | AB | FDA listed | — |
| ciprofloxacin hydrochloride 500 mgthis 12527-8513-09 | Bayer | 83486 tablets | — | — | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 50090-7848-01 | A-S | 14 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 68788-8136-00 | Preferred | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 70518-4214-00 | REMEDYREPACK | 30 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 72189-0111-14 | DIRECT | 14 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 72789-0330-06 | PD-Rx | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 71335-1347-00 | Bryant | 7 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 71335-2046-00 | Bryant | 7 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 72789-0520-06 | PD-Rx | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 72789-0577-14 | PD-Rx | 14 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 85534-0047-00 | HAWAII | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 68788-4177-00 | Preferred | 6 tablets | — | AB | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 67046-1692-03 | Coupler | 30 tablets | — | AB | FDA listed | — |
| Ciprofloxacin 500 mg 67296-2291-04 | Redpharm | 14 tablets | — | AB | FDA listed | — |
| Ciprofloxacin Hydrochloride 500 mg 60760-0847-20 | St. | 20 tablets | — | AB | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Ciprofloxacin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Bayer AG labeler code 12527
- praziquantel 600 mg Tablet, Film Coated NDC 12527-2521-9
- vericiguat 2.5 mg Tablet, Film Coated NDC 12527-5028-1
- vericiguat 5 mg Tablet, Film Coated NDC 12527-5029-1
- vericiguat 10 mg Tablet, Film Coated NDC 12527-5030-1
- sorafenib 200 mg Tablet, Film Coated NDC 12527-8488-9
- ciprofloxacin hydrochloride 250 mg Tablet, Film Coated NDC 12527-8512-9
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full FDA label FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What "drug for further processing" means
FDA lists this package under the "drug for further processing" marketing category: Bayer AG supplies it to other companies for further processing or repackaging (blister cards that are later repackaged or co-packaged are a common example). The units themselves are a finished dosage form — which is why pricing or Medicaid data can still appear — but this exact package code may not be the presentation a retail pharmacy dispenses.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |